Your Article Summary
See Latest ArticlesDenosumab update
Current Opinion in Rheumatology, 06/11/09
Lewiecki EM - Denosumab is a promising therapeutic agent for the management of postmenopausal osteoporosis and rheumatoid arthritis.
Related Articles
Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
The Journal of Urology, 11/16/09
Relevance Score: 87%
A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09
Relevance Score: 83%
Bone health and prostate cancer
Prostate Cancer & Prostatic Diseases, 11/13/09
Relevance Score: 77%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Immunosuppression Using the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus: Pilot Study Shows Significant Cognitive and Affective Improvement
Transplantation Proceedings, 12/16/09
Use of oseltamivir in children
Canadian Family Physician, 12/16/09
The effect of statin therapy on allergic patients with asthma
Annals of Allergy, Asthma, and Immunology, 12/16/09
Today in Women`s Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnosis and management of Henoch–Schonlein purpura
European Journal of Pediatrics, 12/16/09
Australian women's use of complementary and alternative medicines to enhance fertility: exploring the experiences of women and practitioners
BMC Complementary and Alternative Medicine, 12/16/09
Environmental correlates of physical activity in driving and non-driving rural Japanese women
Preventive Medicine, 12/16/09